DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 12 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 1,300 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $3,000 | -25.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -20.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | -50.0% | 1,300 | -43.5% | 0.00% | -50.0% |
| Q2 2021 | $10,000 | -88.1% | 2,300 | -75.0% | 0.00% | -89.5% |
| Q1 2021 | $84,000 | +950.0% | 9,203 | +234.7% | 0.02% | +375.0% |
| Q1 2020 | $8,000 | -38.5% | 2,750 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $13,000 | +225.0% | 2,750 | +37.5% | 0.01% | +150.0% |
| Q3 2019 | $4,000 | -60.0% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $10,000 | -28.6% | 2,000 | -33.3% | 0.00% | -42.9% |
| Q1 2019 | $14,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |